Catalyst Wire Dossier Catalyst Wire Dossier

Fufangdanshen Tablets

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fufangdanshen Tablets, covering 2018-10-23 to 2018-10-23. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Fufangdanshen Tablets in Mild to Moderate Vascular Dementia [Phase 2]

See pricing